Access
To read this story in full you will need to login or make a payment (see right).
News and Views
Nature 394, 527-528 (6 August 1998) | doi:10.1038/28961
Open Innovation Challenges
-
Direct Molecular Detection of Proteins and Nucleic Acids
This Challenge is looking for novel approaches to protein and nucleic acid detection. This is an Id...
-
Single-cell Analysis Platform
This Challenge is looking for novel approaches to analyzing changes at a single-cell level. This is...
- More Challenges
- Powered by:
nature jobs
Chief Scientific Manager - Medicinal Chemistry
- Syngene International
- Bangalore, Karnataka 560099 India
Clinical Trial Analyst
- Indegene Lifesystems Pvt. Ltd
- Bengaluru 560 071 India
Cancer: Proteases — invasion and more
Dylan R. Edwards1 & Gillian Murphy1
The June AACR/APMIS conference*on 'proteases and protease inhibitors in cancer' provided an opportunity to take a good look at the importance of these proteins in cancer biology, particularly for functions other than cellular invasion1. The conference came at an appropriate time, with booming interest in angiogenesis (the formation of new blood vessels) as a therapeutic target and with first-generation synthetic matrix metalloproteinase inhibitors (MMPIs), such as British Biotech's marimastat, hitting the clinic.
- Dylan R. Edwards and Gillian Murphy are in the School of Biological Sciences, University of East Anglia, Norwich, Norfolk NR4 7TJ, UK.
e-mails: Email: dylan.edwards@uea.ac.uk
Email: g.murphy@uea.ac.uk
To read this story in full you will need to login or make a payment (see right).
